この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2013/6/251 分で読めます
Guidance for Industry on Heparin for Drug and Medical Device Use: Monitoring Crude Heparin for Quality; Availability
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "Heparin for Drug and Medical Device Use: Monitoring Crude Heparin for Quality." This guidance was initially published as a draft guidance on February 13, 2012. The draft was revised to clarify FDA's expectations and recommendations and to include references to a recently-developed assay for detecting ruminant contamination of crude heparin.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →